SCHEMBL4377782

SCHEMBL4377782

CCN(CC)CCCCC(N)CCCC(c1ccnc2cc(Cl)ccc12)N(CC)CC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.52
CHRM1 P11229 3/20 0.52
ADRA2C P18825 3/20 0.52
KCNH2 Q12809 3/20 0.52
APP P05067 3/20 0.52
NR4A2 P43354 3/20 0.52
CHRM4 P08173 2/20 0.52
CHRM5 P08912 2/20 0.52
ADRA2A P08913 2/20 0.52
ADRA2B P18089 2/20 0.52
CHRM3 P20309 2/20 0.52
TMEM97 Q5BJF2 2/20 0.52
SIGMAR1 Q99720 2/20 0.52
ACE2 Q9BYF1 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C19 P33261 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
PRNP P04156 1/20 0.52
NQO2 P16083 1/20 0.52
MTOR P42345 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370925 0.93 CHRM2 (0.55) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL16568037 0.81 NR4A2 (0.46) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL16568038 0.78 KCNH2 (0.61) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL30026121 0.76 NR4A2 (0.44) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL4374933 0.75 NR4A2 (0.46) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL8539820 0.73 NR4A2 (0.47) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL4369951 0.73 NR4A2 (0.43) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL1147626 0.72 KCNH2 (0.57) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL1147031 0.72 NR4A2 (0.76) CHRM2CHRM1ADRA2CKCNH2APP
SCHEMBL3018921 0.72 CHRM2 (0.49) CHRM2CHRM1ADRA2CKCNH2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009148659-A2 ANTIMALARIAL QUINOLINES AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2009-12-10 WO disclosed